Pendulum is a team made up of experts in microbiology, biochemistry, medicine and nutrition, including Colleen Cutcliffe Ph.D
About 1 in 8 adults are now taking a GLP-1 drug for obesity, disease, or both, up 6 percentage points from May 2024, according to KFF poll results released in November
Obes Surg 34(4):13241332 Lautenbach A, Wernecke M, Stoll FD, Meyhfer SM, Meyhfer S, Aberel J
Popular GLP-1 weight-loss drugs linked to lower risks of addiction and overdose Popular weight-loss drugs may also help silence the cravings behind addiction, reducing risks across alcohol, nicotine, opioids, and other substances
Overall, existing secondary research provides a relatively solid, yet imperfect, evidence base for the metabolic benefits of GLP-1RAs in PCOS
Insoluble fiber does not dissolve